Know Cancer

or
forgot password

Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers


Phase 2
18 Years
N/A
Not Enrolling
Both
Inoperable Early Stage Non-small Cell Lung Cancer

Thank you

Trial Information

Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers


Inclusion Criteria:



- Proof of cT1a/b - 2a/b N0M0 NSCLC

- Informed Consent signed

- Resectable tumour

- > 18 years old

- men and women

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

development and validation of a multi-variate predictive model

Outcome Description:

To develop and validate a multi-variate predictive model based on bio-imaging and biomarkers for progression)free survival from 2 to 5 years.

Outcome Time Frame:

from 2 to 5 years

Safety Issue:

No

Principal Investigator

Jan Van Meerbeeck, MD,PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital, Ghent

Authority:

Belgium: Ethics Committee

Study ID:

2010/205

NCT ID:

NCT01138748

Start Date:

November 2010

Completion Date:

October 2012

Related Keywords:

  • Inoperable Early Stage Non-small Cell Lung Cancer
  • inoperable early stage non-small cell lung cancer
  • radiation therapy
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location